Author

Killian S. Hanlon

Harvard UniversityORCID 0000-0002-3957-6061Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Carrie Ng· 2 shared Casey A. MaguireiD· 2 shared Demitri de la Cruz· 2 shared Miguel C. SantoscoyiD· 2 shared Paula EspinozaiD· 2 shared Ana Griciuc· 1 shared Boram LeeiD· 1 shared Christian E. BadriD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Carrie Ng

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintSep 25, 2024

Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in mice

Miguel C. Santoscoy, Paula Espinoza, Killian S. Hanlon…·Casey A. Maguire

The paper identifies an AAV capsid, MC5, that efficiently and specifically transduces microglia via direct and intracerebroventricular injection in mice.

2 citations

mouseexperimental assay

𝕏 PostBluesky

BioengineeringMolecular TherapyPeer-reviewedJun 5, 2024

In vivo selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cord

Killian S. Hanlon, Ming Liang Cheng, Roberto Montoro Ferrer…·Casey A. Maguire

The paper identifies superior AAV capsids for targeted spinal cord gene therapy in non-human primates through in vivo selection and evaluates their biodistribution and expression.

14 citations

non-human primateexperimental assay

𝕏 PostBluesky